Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms.
Duarte, D.P., Lamontanara, A.J., La Sala, G., Jeong, S., Sohn, Y.K., Panjkovich, A., Georgeon, S., Kukenshoner, T., Marcaida, M.J., Pojer, F., De Vivo, M., Svergun, D., Kim, H.S., Dal Peraro, M., Hantschel, O.(2020) Nat Commun 11: 2319-2319
- PubMed: 32385234 
- DOI: 10.1038/s41467-020-16128-5
- Primary Citation of Related Structures:  
6HTF - PubMed Abstract: 
Bruton's tyrosine kinase (Btk) is critical for B-cell maturation and activation. Btk loss-of-function mutations cause human X-linked agammaglobulinemia (XLA). In contrast, Btk signaling sustains growth of several B-cell neoplasms which may be treated with tyrosine kinase inhibitors (TKIs) ...